The Vif (viral infectivity factor) protein of human immunodeficiency virus-1 (HIV-1) is essential for the production of infectious virus by T lymphocytes and macrophages, the natural targets for HIV-1 infection. Vif is dispensable for HIV infection in certain transformed cell lines ("permissive" cells) but is required for propagative infection in others ("nonpermissive" cells). Vif is thought to inhibit an antiviral pathway recently demonstrated to require the cellular protein CEM 15 (1). This protein, also called APOBEC3G (2) , is a member of the family of cytidine deaminases. Because recent studies have suggested that some mammalian cytidine deaminases target single-stranded DNA (3), we tested the hypothesis that Vif may be required to prevent the editing of minusstrand viral DNA synthesized by virions produced in nonpermissive cells. Thus, nonpermissive H9 cells (4) were exposed to virus produced by HeLa cells transfected with wild-type HIV-1 ( pNL4-3) or a variant in which a portion of the vif gene had been deleted (⌬vif). The virions produced by H9 cells 24 to 48 hours after infection were recovered. Target cells (CD4 ϩ , HeLa-derived P4 cells) were then exposed to these virions and incubated for 5 hours at 37°C, and newly reverse transcribed viral DNA was isolated (4) . Degenerate primers that would not be affected by the editing of minusstrand DNA by cytidine deaminases were then used to amplify viral sequences in env and U5. The products were then cloned and sequenced. Guanine to adenine (G3 A) changes were significantly more frequent in DNA synthesized by ⌬vif virions than in DNA produced by wildtype virions (P Ͻ 0.0001 and P Ͻ 0.01) ( G3 A changes in the HIV plus-strand DNA can be directly explained by modifications of cytidine to uridine (C3 U) in the minus-strand of DNA by a cytidine deaminase, because U is subsequently read as T by DNA polymerases. Such changes might also be compatible with hypermutation by reverse transcriptase, a phenomenon markedly accentuated by low intracellular deoxycytidine triphosphate to deoxythymidine triphosphate (dCTP/dTTP) ratios (5) . Because the dCTP/dTTP ratio present in P4 cells is not conducive to hypermutation (6) and because base changes were only frequent when virions were produced by nonpermissive cells in the absence of Vif, this mechanism seems less likely. Similarly, the editing of viral RNA by a cytidine deaminase would not explain our findings, because C3 T changes and not G3 A changes in the DNA plus strand would then be expected. Indeed, when RNA was extracted from ⌬vif virions produced by H9 cells during the first 24 hours after infection, reverse-transcribed with Moloney murine leukemia virus reverse transcriptase (M-MLV RT), and amplified, no G3 A changes could be observed in these cDNA sequences (Fig. 1B) . However, when these virions were used to synthesize viral DNA by endogenous reverse transcription within the viral particles (4), numerous G3 A changes were seen (Fig. 1C) . G3 A changes were not observed when endogenous reverse transcription was performed using wild-type viruses produced by H9 cells or ⌬vif viruses produced by permissive cells (Fig. 1C) (6) .
Overall, our results indicate that in the absence of Vif, virions produced in nonpermissive H9 cells contain an activity that results in the introduction of C3 U changes into the minus-strand of viral DNA synthesized during reverse transcription, a feature that is highly compatible with editing of the minus-strand by a cytidine deaminase, such as CEM 15/APOBEC3G (1). Thus, when HIV replicates in cells expressing CEM 15/APOBEC3G, the Vif protein, through mechanisms that remain to be defined, is able to prevent the accumulation of multiple defects in structural, enzymatic, and regulatory viral proteins that would otherwise result in failure at several points in the HIV life cycle. 
